1887

Abstract

Forty carbapenem-resistant isolates were recovered from 28 patients from various sites in an intensive care unit in Zhejiang Provincial People’s Hospital, China, over a 6 month period. PFGE analysis indicated that the 40 strains were all closely related. The MICs of carbapenems varied from 16 to >256 µg ml. Conjugation studies with resulted in the transfer of reduced carbapenem susceptibility from the original isolates. All and transconjugants produced carbapenemase 2 (KPC-2), and most of them produced TEM, SHV and CTX-M. Additionally, 27 isolates and 27 transconjugants carried the gene (25 were and 2 were ). harboured several plasmids, and was located on a 55 kb plasmid. SDS-PAGE and gene sequence analysis of OMPs suggested that porins in are expressed normally. The MICs of the carbapenems did not change in the presence of CCCP. Thus, production of KPC-2 appears to play an important role in resistance to carbapenems, although other mechanisms may be involved. The gene is associated with several antibiotic-resistance genes, such as , , and .

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.015826-0
2011-07-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/7/977.html?itemId=/content/journal/jmm/10.1099/jmm.0.015826-0&mimeType=html&fmt=ahah

References

  1. Cai J. C., Zhou H. W., Chen G.-X., Zhang R. 2008a). [Detection of plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae.]. Zhonghua Yi Xue Za Zhi 88:135–138 (in Chinese) [PubMed]
    [Google Scholar]
  2. Cai J. C., Zhou H. W., Zhang R., Chen G.-X. 2008b). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 52:2014–2018 [View Article][PubMed]
    [Google Scholar]
  3. Chmelnitsky I., Navon-Venezia S., Strahilevitz J., Carmeli Y. 2008; Plasmid-mediated qnrB2 and carbapenemase gene bla KPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob Agents Chemother 52:2962–2965 [View Article][PubMed]
    [Google Scholar]
  4. CLSI 2006 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th edn. approved standard M7–A7 (M100–S16) Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  5. Cuzon G., Naas T., Demachy M. C., Nordmann P. 2008; Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 52:796–797 [View Article][PubMed]
    [Google Scholar]
  6. Dortet L., Radu I., Gautier V., Blot F., Chachaty E., Arlet G. 2008; Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. J Antimicrob Chemother 61:455–457 [View Article][PubMed]
    [Google Scholar]
  7. Endimiani A., Carias L. L., Hujer A. M., Bethel C. R., Hujer K. M., Perez F., Hutton R. A., Fox W. R., Hall G. S. et al. 2008; Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing bla KPC in the United States. Antimicrob Agents Chemother 52:2680–2682 [View Article][PubMed]
    [Google Scholar]
  8. Hasdemir U. O., Chevalier J., Nordmann P., Pagès J.-M. 2004; Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 42:2701–2706 [View Article][PubMed]
    [Google Scholar]
  9. Hernández-Allés S., Albertí S., Alvarez D., Doménech-Sánchez A., Martínez-Martínez L., Gil J., Tomás J. M., Benedí V. J. 1999; Porin expression in clinical isolates of Klebsiella pneumoniae . Microbiology 145:673–679 [View Article][PubMed]
    [Google Scholar]
  10. Jiang Y., Zhou Z., Qian Y., Wei Z., Yu Y., Hu S., Li L. 2008; Plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother 61:1003–1006 [View Article][PubMed]
    [Google Scholar]
  11. Kaczmarek F. M., Dib-Hajj F., Shang W., Gootz T. D. 2006; High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 50:3396–3406 [View Article][PubMed]
    [Google Scholar]
  12. Leavitt A., Navon-Venezia S., Chmelnitsky I., Schwaber M. J., Carmeli Y. 2007; Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51:3026–3029 [View Article][PubMed]
    [Google Scholar]
  13. Martínez-Martínez L., Pascual A., García I., Tran J., Jacoby G. A. 2003; Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother 51:1037–1039 [View Article][PubMed]
    [Google Scholar]
  14. Mathew A., Harris A. M., Marshall M. J., Ross G. W. 1975; The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 88:169–178[PubMed] [CrossRef]
    [Google Scholar]
  15. Mendes R. E., Bell J. M., Turnidge J. D., Yang Q., Yu Y., Sun Z., Jones R. N. 2008; Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (bla KPC-2 plus qnrB4) and a bla IMP-4 gene. Antimicrob Agents Chemother 52:798–799 [View Article][PubMed]
    [Google Scholar]
  16. Miriagou V., Tzouvelekis L. S., Rossiter S., Tzelepi E., Angulo F. J., Whichard J. M. 2003; Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 47:1297–1300 [View Article][PubMed]
    [Google Scholar]
  17. Monteiro J., Santos A. F., Asensi M. D., Peirano G., Gales A. C. 2009; First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 53:333–334 [View Article][PubMed]
    [Google Scholar]
  18. Naas T., Nordmann P., Vedel G., Poyart C. 2005; Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 49:4423–4424 [View Article][PubMed]
    [Google Scholar]
  19. Naas T., Cuzon G., Villegas M. V., Lartigue M. F., Quinn J. P., Nordmann P. 2008; Genetic structures at the origin of acquisition of the β-lactamase bla KPC gene. Antimicrob Agents Chemother 52:1257–1263 [View Article][PubMed]
    [Google Scholar]
  20. Nordmann P., Cuzon G., Naas T. 2009; The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–236 [View Article][PubMed]
    [Google Scholar]
  21. Pérez-Pérez F. J., Hanson N. D. 2002; Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153–2162 [View Article][PubMed]
    [Google Scholar]
  22. Poirel L., Pitout J. D., Calvo L., Rodriguez-Martinez J.-M., Church D., Nordmann P. 2006; In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob Agents Chemother 50:1525–1527 [View Article][PubMed]
    [Google Scholar]
  23. Queenan A. M., Bush K. 2007; Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20:440–458 [View Article][PubMed]
    [Google Scholar]
  24. Robicsek A., Strahilevitz J., Sahm D. F., Jacoby G. A., Hooper D. C. 2006; qnr Prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50:2872–2874 [View Article][PubMed]
    [Google Scholar]
  25. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239[PubMed]
    [Google Scholar]
  26. Tsakris A., Kristo I., Poulou A., Markou F., Ikonomidis A., Pournaras S. 2008; First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 62:1257–1260 [View Article][PubMed]
    [Google Scholar]
  27. Wei Z.-Q., Du X.-X., Yu Y.-S., Shen P., Chen Y.-G., Li L.-J. 2007; Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 51:763–765 [View Article][PubMed]
    [Google Scholar]
  28. Yigit H., Queenan A. M., Anderson G. J., Domenech-Sanchez A., Biddle J. W., Steward C. D., Alberti S., Bush K., Tenover F. C. 2001; Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae . Antimicrob Agents Chemother 45:1151–1161 [View Article][PubMed]
    [Google Scholar]
  29. Yigit H., Queenan A. M., Rasheed J. K., Biddle J. W., Domenech-Sanchez A., Alberti S., Bush K., Tenover F. C. 2003; Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2. Antimicrob Agents Chemother 47:3881–3889 [View Article][PubMed]
    [Google Scholar]
  30. Yu Y., Ji S., Chen Y., Zhou W., Wei Z., Li L., Ma Y. 2007; Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J Infect 54:53–57 [View Article][PubMed]
    [Google Scholar]
  31. Zhang R., Zhou H. W., Cai J. C., Chen G.-X. 2007; Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother 59:574–576 [View Article][PubMed]
    [Google Scholar]
  32. Zhang R., Yang L., Cai J. C., Zhou H. W., Chen G.-X. 2008; High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 57:332–337 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.015826-0
Loading
/content/journal/jmm/10.1099/jmm.0.015826-0
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error